snyderman nancy lynn MD insider trades
snyderman nancy lynn MD has filed 23 Form 4s with the SEC that we hold, for Alkermes plc. (ALKS) (Director), AXNX (Director), Lyra Therapeutics, Inc. (LYRA) (Director) and FHLT (Director). Across all of them we count 1 purchase worth $10.0K and 1 sale worth $2.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($2.2M). The largest single trade was a sale of 44,472 shares of Alkermes plc. worth $2.2M, dated 2026-08-03. The first filing on our record is dated 2021-09-16 and the latest 2026-08-03.
Alkermes plc. (ALKS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-03-04 | P, purchase reported on Form 4 | 427 | $10.0K | 2022-03-08 |
| 2026-08-03 | S, sale reported on Form 4 | 44,472 | $2.2M | 2026-08-03 |
AXNX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Lyra Therapeutics, Inc. (LYRA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
FHLT
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1675198) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms